JENNIFER DEWOLF: Open Payments
NPI 1952754632 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 36 payments from 10 companies in 2025. Trend: 2023 $1,151 · 2024 $862 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $515 |
| GlaxoSmithKline, LLC. | 6 | $109 |
| Exact Sciences Corporation | 2 | $37 |
| Amgen Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: UBRELVY, QULIPTA, SHINGRIX, The Cologuard Plus Collection Kit, OTEZLA, REXULTI, SYNTHROID, BEXSERO.
Industry payments across NY — which companies pay providers there.
